The report has classified the global Human Immunoglobulin Ph4 For Intravenous Injection market into segments including product type and application. Every segment is evaluated based on share and ...
April 21, 2010 — The US Food and Drug Administration (FDA) has approved an extended shelf life for 10% liquid intravenous immunoglobulin injection (Privigen, CSL Behring), making it the first product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results